OLIG2 (for WB only) Monoclonal antibody proteintech 66513-1-Ig

$449.00
In stock
SKU
66513-1-Ig

 

OLIG2, 1E8C5, 5O7, bHLHb1, bHLHe19

Host / Isotype: Mouse / IgG2a Class: Monoclonal
Reactivity: human Immunogen: CatNo: Ag18838 Product name: Recombinant human OLIG2 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-323 aa of BC047511 Sequence: MDSDASLVSSRPSSPEPDDLFLPARSKGSSGSAFTGGTVSSSTPSDCPPELSAELRGAMGSAGAHPGDKLGGSGFKSSSSSTSSSTSSAAASSTKKDKKQMTEPELQQLRLKINSRERKRMHDLNIAMDGLREVMPYAHGPSVRKLSKITTLLLARNYILMLTNSLEEMKRLVSEIYGGHHAGFHPSACGGLAHSAPLPAATAHPAAAAHAAHHPAVHHPILPPAAAAAAAAAAAAAVSSASLPGSGLPSVGSIRPPHGLLKSPSAAAAAPLGGGGGGSGASGGFQHWGGMPCPCSMCQVPPPHHHVSAMGAGSLPRLTSDAK Predict reactive species
 Applications: WB, ELISA Observed Molecular Weight: 32 kDa
Formulation: PBS, Azide, Glycerol GenBank Accession Number: BC047511
Conjugate: Unconjugated Gene Symbol: OLIG2
Tested Applications: Positive WB detected in Gene ID (NCBI): 10215
Application: Western Blot (WB) RRID: AB_2881876
Dilution: WB : 1:1000-1:6000 Conjugate: Unconjugated
Tested Reactivity: Human Form: Liquid
Host / Isotype: Mouse / IgG2a Background Information: OLIG2, also named as BHLHB1, BHLHE19, PRKCBP2 and RACK17, is required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Cooperates with OLIG1, OLIG2 establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development. OLIG2 is widely expressed in subsets of glia cells and progenitors, and it is strongly induced at different sites by both acute and chronic injury, albeit with different mechanisms. OLIG2 acts as a repressor of neurogenesis in cells reacting to brain injury. It may represent an effective approach towards evoking neuronal repair from parenchymal precursors.(PMID:19390819 )

 

 

Reviews

Write Your Own Review
You're reviewing:OLIG2 (for WB only) Monoclonal antibody proteintech 66513-1-Ig
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.